VivoSeq
Other

Corticosteroids

0

Pipeline Programs

8

Active Trials

6

Companies Involved

Corticosteroids is an early-stage landscape with 0 programs across 6 companies. The most active players are Merck & Co., Boehringer Ingelheim, Biogen.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

72/100

Attrition Rate

20/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

59

clinical trials

Completed31 · 53%
Terminated10 · 17%
Unknown status8 · 14%
Recruiting4 · 7%
Not yet recruiting2 · 3%
Withdrawn2 · 3%
Other2 · 3%

Trial Activity

59 trials

Air Pollution and Inhaled Corticosteroids in COPD
Not yet recruiting·UUniversity of British Columbia·Phase 4·NCT06552364·48 enrolled
Cost-effectiveness Analysis of Three Corticosteroids in ILDs
Completed··N/A·NCT04982809·107 enrolled
Corticosteroids in Community Acquired Pneumonea
Completed··N/A·NCT01228110·80 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)